3Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007 [J]. CA Cancer J Clin, 2007, 57(1): 43-66.
4Yajima T, Nishimura H, Wajjwalku W, et al. Overexpression of interleukin- 15 in vivo enhances antitumor activity against MHC class I-negative and -positive malignant melanoma through augmented NK activity and cytotoxic T cell response [J]. Int J Cancer, 2002, 99(4): 573-578.
5Diab A, Cohen AD, Mpdogan O, et al. IL-15: targeting CD8+ T cell for immunotherapy [J]. Cytotherapy, 2005, 7 (1):23-35.
6Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression [J]. Immunity, 2009, 30(5): 636-645.
7Boyiadzis M, Memon S, Carson J, et al. Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels [J]. Biol Blood Marrow Transplant, 2008, 14(3): 290-300.
